Generali Investments, Management Co LLC
Source: SEC Form 13F · as of Mar 2026Generali Investments, Management Co LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $51.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$51.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 8,699 | $8.0M |
| JNJJOHNSON & JOHNSON | 29,754 | $7.3M |
| ABBVAbbVie Inc. | 27,096 | $5.9M |
| PFEPFIZER INC | 189,601 | $5.3M |
| MRKMerck & Co., Inc. | 43,191 | $5.2M |
| AMGNAMGEN INC | 8,498 | $3.0M |
| ABTABBOTT LABORATORIES | 22,586 | $2.3M |
| GILDGILEAD SCIENCES, INC. | 15,555 | $2.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,042 | $1.6M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,366 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,994 | $1.4M |
| BIIBBIOGEN INC. | 7,112 | $1.3M |
| NBIXNEUROCRINE BIOSCIENCES INC | 8,882 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 17,276 | $1.0M |
| MCKMcKesson Corporation | 1,014 | $877K |
| CORCencora Inc. | 2,578 | $810K |
| PMPhilip Morris International Inc | 3,423 | $566K |
| GEHCGE HealthCare Technologies Inc. | 5,800 | $413K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,227 | $406K |
| IDXXIDEXX LABORATORIES INC /DE | 640 | $360K |
| ELVElevance Health Inc. | 782 | $229K |
| STOKStoke Therapeutics, Inc. | 6,912 | $225K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.